Genetically Tailored Cancer Treatments Spark Controversy In Medical Commumity

Experts are having a lively debate over a booming cancer treatment field called 'precision oncology.'
Drugs can be custom-tailored to fit the genetic makeup of cancerous tumors.
The FDA has endorsed the first “tissue-agnostic” immunotherapy drug.
It's now approved for any advanced solid tumor with flaws in genes that repair DNA.
But detractors say the number of patients targeted cancer therapies could benefit is small.